{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:16:42Z","timestamp":1777378602058,"version":"3.51.4"},"reference-count":20,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Drug Development and Industrial Pharmacy"],"published-print":{"date-parts":[[2019,12,2]]},"DOI":"10.1080\/03639045.2019.1680993","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T22:08:36Z","timestamp":1571177316000},"page":"1915-1920","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["An evaluation of the pharmacokinetics of tiotropium following a single-dose inhalation in healthy subjects using an ultra-sensitive bioanalytical method"],"prefix":"10.1080","volume":"45","author":[{"given":"Mohammed","family":"Bouhajib","sequence":"first","affiliation":[{"name":"Pharma Medica Research Inc, Mississauga, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7006-9244","authenticated-orcid":false,"given":"Zia","family":"Tayab","sequence":"additional","affiliation":[{"name":"Pharma Medica Research Inc, Mississauga, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,10,24]]},"reference":[{"key":"CIT0001","unstructured":"Boehringer Ingelheim Pharmaceuticals, Inc. Highlights of prescribing information. Spiriva\u00ae HandiHaler\u00ae (tiotropium bromide inhalation powder), for oral inhalation use. U.S. FDA Revised 2\/2018; 2018; [cited 2018 Mar 26]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/021395s048lbl.pdf"},{"key":"CIT0002","unstructured":"Boehringer Ingelheim International GmbH. Summary of product characteristics. Spiriva 18 microgram inhalation powder, hard capsule. Europe: MHRA Revised 10\/2016; 2016; [cited 2018 Mar 26]. Available from: http:\/\/www.mhra.gov.uk\/home\/groups\/spcpil\/documents\/spcpil\/con1520572472405.pdf"},{"key":"CIT0003","first-page":"CD009552","author":"Cheyne L","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"CIT0004","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Pocket guide to COPD diagnosis, management, and prevention: a guide for health care professionals; 2017; [cited 2018 Feb 23]. Available from: http:\/\/goldcopd.org\/wp-content\/uploads\/2016\/12\/wms-GOLD-2017-Pocket-Guide.pdf"},{"issue":"2","key":"CIT0005","first-page":"95","volume":"2","author":"Rice KL","year":"2007","journal-title":"Int J Chron Obst Pulmon Dis"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1177\/1715163516660573"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2009.0785"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201604-0733OC"},{"key":"CIT0009","unstructured":"Center for Drug Evaluation and Research. Application number 21-395: clinical pharmacology and biopharmaceutics review(s); 2001; [cited 2018 Feb 23]. Available from: http:\/\/www.fda.gov"},{"key":"CIT0010","unstructured":"Committee for Medicinal Products for Human Use (CHMP). Guideline on the investigation of bioequivalence; 2010; [cited 2018 Feb 26]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2010\/01\/WC500070039.pdf"},{"issue":"5","key":"CIT0011","first-page":"431","volume":"146","author":"Vetch\u00fd D","year":"2007","journal-title":"Cas Lek Cesk"},{"key":"CIT0012","unstructured":"United States Department of Health and Human Services, Food and Drug Administration. Guidance for industry: bioanalytical method validation: draft guidance; 2013; [cited 2018 Mar 26]. Available from: https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm070107.Pdf"},{"key":"CIT0013","unstructured":"European Medicines Agency. Guideline on bioanalytical method validation: draft guidance; 2011; [cited 2018 Mar 26]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/08\/WC500109686.pdf"},{"key":"CIT0014","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline: clinical safety data management: definitions and standards for expedited reporting: E2A; 1994; [cited 2018 Feb 23]. Available from: http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E2A\/Step4\/E2A_Guideline.pdf"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.215"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2015.1260"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.4155\/bio.15.256"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.3021"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-016-0441-8"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(99)00341-5"}],"container-title":["Drug Development and Industrial Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03639045.2019.1680993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T10:05:30Z","timestamp":1615975530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03639045.2019.1680993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,24]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12,2]]}},"alternative-id":["10.1080\/03639045.2019.1680993"],"URL":"https:\/\/doi.org\/10.1080\/03639045.2019.1680993","relation":{},"ISSN":["0363-9045","1520-5762"],"issn-type":[{"value":"0363-9045","type":"print"},{"value":"1520-5762","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iddi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iddi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-04-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}